Health Insurance: Factors Influencing the Utilization of Health Insurance Schemes by Medical Doctors in Lagos State, South-West Nigeria
DOI:
https://doi.org/10.54536/ajiri.v4i3.5588Keywords:
Factors, Health Insurance Schemes, Health Insurance, Health, Influence, Lagos State, Medical Doctors, Mushin, South-West Nigeria, UtilizationAbstract
Health insurance is an important determinant of access to healthcare services worldwide. In Nigeria, different health insurance schemes are available but their level of utilization differs among the population. Social and private health insurance schemes are trying to achieve up to 20% coverage. Using a target population in a specific location, this research aimed to study the factors influencing the utilization of health insurance schemes by medical doctors in Mushin Local Government Area (LGA) of Lagos State, South-West Nigeria. This research is a cross-sectional descriptive study and involved 300 medical doctors who were selected in Mushin LGA using a multi-stage sampling technique. A structured, self-administered questionnaire was used to collect data from the respondents. Data was analyzed using SPSS version 26, and statistical significance was set at p-value<0.05. Bivariate analysis was used to describe the dependent and the independent variables. Chi-square and logistic regression (where appropriate) were used to test for association between independent and dependent variables. Many of the respondents were aware of existing different health insurance schemes. Six factors influencing the utilization of health insurance schemes were identified such as prolonged waiting time (87.0%), use of substandard drugs for enrollees (86.0%), shortage of drugs (out-of-stock medicines) (86.3%), poor attitude of healthcare workers (72.3%), insurance scheme does not cover some healthcare services and drugs (89.7%), and lastly, stringent and unsatisfactory terms and conditions of health insurance schemes (85.0%). The design and delivery of health insurance schemes should be improved upon by the stakeholders, in order to make health insurance attractive to the general population.
Downloads
References
Adebisi, S. A., Odiachi, J. M., & Chikere, N. A. (2019). The National Health Insurance Scheme (NHIS) in Nigeria: Has the Policy Achieved its Intended Objectives? Academic Journal of Economic Studies, 5(3), 97-104.
Adebiyi, O., & Adeniji, F. O. (2021). Factors Affecting Utilization of the National Health Insurance Scheme by Federal Civil Servants in Rivers State, Nigeria. INQUIRY: The Journal of Health Care Organization, Provision, and Financing, 58, 1–8. https://doi.org/10.1177/00469580211017626.
Adewole, D. A., Reid, S., Oni, T., & Adebowale, A. S. (2022). Factors Influencing Satisfaction with Service Delivery Among National Health Insurance Scheme Enrollees in Ibadan, Southwest Nigeria. J Patient Exp, 9, 23743735221074186. https://doi.org/10.1177/23743735221074186.
Akinyemi, O. O., Owopetu, O. F., & Agbejule, I. O. (2021). National Health Insurance Scheme: Perception and participation of federal civil servants in Ibadan. Ann Ib Postgrad Med, 19(1), 49-55.
Alawode, G. O., & Adewole, D. A. (2021). Assessment of the design and implementation challenges of the National Health Insurance Scheme in Nigeria: a qualitative study among sub-national level actors, healthcare and insurance providers. BMC Public Health, 21(1), 124. https://doi.org/10.1186/s12889-020-10133-5.
Aliu-Ayo, H. I., Adesina, K. T., Jimoh, A. A. G., Ikwuka, A. O., Udeh, F. C., Biliaminu, S. A., & Ayo, O. W. (2023)a. Serum Levels of Thyroid Hormones in Infertile and Fertile Women Attending a Tertiary Care Hospital in North-Central Nigeria: A Comparative Reproductive Medicine Study. American Journal of Medical Science and Innovation, 2(2), 141-152. https://doi.org/10.54536/ajmsi.v2i2.2044.
Aliu-Ayo, H. I., Adesina, K. T., Jimoh, A. A. G., Ikwuka, A. O., Udeh, F. C., Biliaminu, S. A., & Ayo, O. W. (2023)b. Correlation of Thyroid Gland Functions with Menstrual Patterns amongst Infertile and Fertile Women Attending a Tertiary Care Hospital in North-Central Nigeria. World Journal of Clinical Medicine Research, 3(1), 13–26. https://doi.org/10.31586/wjcmr.2023.787.
Ama, M. I., Ikwuka, A. O., Udeh, F. C., Ekechi, H. O., & Eteudo, A. N. (2023). Sperm Parameters and Testicular Histology of Male Wistar Rats Treated with Phoenix dactylifera After Consumption of Local Mmahi Salt. American Journal of Bioscience and Bioinformatics, 2(1), 41-51. https://doi.org/10.54536/ajbb.v2i1.2275.
Aregbeshola, B. S., & Khan, S. M. (2018). Predictors of Enrolment in the National Health Insurance Scheme Among Women of Reproductive Age in Nigeria. Int J Health Policy Manag, 7(11), 1015-1023. https://doi.org/10.15171/ijhpm.2018.68.
Azeez, Y., Babatunde, Y., Babatunde, D., Olasupo, J., Alabi, E., Bakare, P., & Adedeji, O. (2021). Towards Universal Health Coverage: An Analysis of the Health Insurance Coverage in Nigeria. International Journal of Health and Life Sciences. https://doi.org/10.5812/ijhls.108727.
Baggio, S., Dupuis, M., Wolff, H., & Bodenmann, P. (2018). Associations of lack of voluntary private insurance and out-of-pocket expenditures with health inequalities: Evidence from an international longitudinal survey in countries with universal health coverage. PLoS One, 13(10), e0204666. https://doi.org/10.1371/journal.pone.0204666.
Baharin, M. F., & Juni, M. (2019). Determinants of Out-of-pocket Expenditure for Health Care: A Systematic Review. International Journal of Public Health and Clinical Sciences, 6, 44-58. https://doi.org/10.32827/ijphcs.6.2.44.
Baysah, P. V., Ikwuka, A. O., Udeh, F. C., Bleh, D. P., & Viloria, T. (2023). Pathophysiological Effects of Alcohol and Tobacco Consumption on Semen Parameters of Men Attending a Fertility Clinic in West Africa. American Journal of Biomedical and Life Sciences, 11(4), 73-81. https://doi.org/10.11648/j.ajbls.20231104.13. 12.
Chowdhury, J., & Ravi, R. (2022). Healthcare Accessibility in Developing Countries: A Global Healthcare Challenge. Journal of Clinical & Biomedical Research, 4, 1-5. Https://doi.org/10.47363/JCBR/2022(4)152.
Egbewole, T. A., Ncube, F., & Ikwuka, A. O. (2024)a. Impact of SDG3 in The Prevention of Physical and Mental Effects of Infertility Observed in Nigerian Women: A Scoping Review. American Journal of Life Science and Innovation, 3(2), 33-45. https://doi.org/10.54536/ajlsi.v3i2.3139.
Egbewole, T. A., Ncube, F., & Ikwuka, A. O. (2024)b. Concordance and Discordance of Opinions on the Impact of SDG3 on Infertility among Nigerian Women: A Perspective Review. Merit Research Journal of Medicine and Medical Sciences, 12(10), 203-218. https://doi.org/10.5281/zenodo.14000760.
Emmanuel, S. B. (2022). The Current State of the Nigerian Healthcare Sector and Strategies for Transforming It. https://doi.org/10.13140/RG.2.2.19858.32965.
Esan, J. O., Ishola, A. G., Ikwuka, A. O., Esan, B. A., & Saanu, O. O. (2025)a. Neuman Systems Model and Quality of Life in Individuals with Infertility: An Objective Review. Merit Research Journal of Medicine and Medical Sciences, 13(2), 022-035. https://doi.org/10.5281/zenodo.15224685.
Esan, J. O., Akpan, M. I., Ikwuka, A. O., & Esan, B. A. (2025)b. Women’s Health: Dimensions of Depression, Coping Strategies and Social Support Among Infertile Women - A Perspective Review. European Journal of Medical and Health Research, 3(3), 194-205. https://doi.org/10.59324/ejmhr.2025.3(3).29.
Ilesanmi, O. S., Afolabi, A. A., & Adeoya, C. T. (2023). Driving the implementation of the National Health Act of Nigeria to improve the health of her population. Pan Afr Med J, 45, 157. https://doi.org/10.11604/pamj.2023.45.157.37223.
Ikwuka, A. O. (2015). Risk factors for the pathogenesis of diabetes mellitus type 2. Materials of 84th Scientific and Practical Conference of Students and Young Scientists with International Participation “Innovations in medicine” (pp. 19). Available online: http://www.ifnmu.edu.ua/images/snt/files/konferenciya/Tezu_2015.pdf
Ikwuka, A. O. (2017a). Dyslipidemia risk severity in patients with diabetes mellitus type 2 and essential hypertension. Journal of the 21st International Medical Congress of Students and Young Scientists, 59.
Ikwuka, A. O. (2017b). Effectiveness of dapagliflozin in patients with diabetes mellitus type 2 and essential hypertension. Book of abstracts of the 7th International Students’ Scientific Conference of Young Medical Researchers, p. 102. Available online: http://www.stn.umed.wroc.pl/files/lm/Accepted_papers.16113.pdf
Ikwuka, A. O. (2017c). Influence of dyslipidemia in patients with diabetes mellitus type 2 and essential hypertension. The Pharma Innovation Journal, 6(3), 101-103. Available online: http://www.thepharmajournal.com/archives/?year=2017&vol=6&issue=3&part=B
Ikwuka, A. O., & Haman, I. O. (2017d). Features of kidney damage in patients with diabetes mellitus type 2 and essential hypertension. Journal of 86th Scientific and Practical Conference of Students and Young Scientists with International Participation “Innovations in medicine”, p. 144. Available online: http://www.ifnmu.edu.ua/images/snt/86-konf-tezi%20(1).pdf
Ikwuka, A. O., Virstyuk, N. G., & Luchko, O. R. (2017)e. Features of the functional state of kidneys in patients with diabetes mellitus type 2 and essential arterial hypertension. Materials of scientific-practical conference with international participation “Babenkivski reading”, p. 48.
Ikwuka, A. O. (2018)a. Clinical dynamics in patients with diabetes mellitus type 2 and concomitant essential hypertensive disease treated with dapagliflozin. Journal of the 22nd International Medical Congress of Students and Young Scientists, p. 32.
Ikwuka, A. O. (2018)b. Clinical effectiveness of SGLT-2 inhibitors in patients with diabetes mellitus type 2 and essential hypertensive disease. Endocrine Practice, 24(1), 74. https://doi.org/10.1016/S1530-891X(20)47129-0.
Ikwuka, A. O. (2018c). Features of kidney damage in patients with arterial hypertension and type 2 diabetes mellitus and optimization of treatment. Specialized Academic Council IFNMU, Available online: http://www.ifnmu.edu.ua/images/zagalna_informacia/spec_vcheni_radi/2017-2019/%D0%9420.601.01/Ikvuka/Avtoreferat.pdf
Ikwuka, A. O., & Paliy, Yu. (2018d). Structural changes of the left ventricular myocardium in patients with essential arterial hypertension and diabetes mellitus type 2. Abstracts of the 87th Scientific Conference of Students and Young Scientists with International Participation “Innovations in medicine”, 25-26. Available online: https://www.ifnmu.edu.ua/images/snt/zaproshennia_eng.pdf
Ikwuka, A. O. (2019a). Clinical dynamics of nephropathy in patients with diabetes mellitus type 2 and concomitant essential hypertensive disease. Clinical Medicine, 19(2), s39. https://doi.org/10.7861/clinmedicine.19-2-s39.
Ikwuka, A. O. (2019b). Clinical effectiveness of GLP-1 RAs in patients with metabolic syndrome diseases. Endocrine Practice, 25(1), 104-105. https://doi.org/10.1016/S1530-891X(20)46611-X.
Ikwuka, A. O., & Virstyuk, N. G. (2019c). Pattern of cardiac remodelling of the left ventricle in patients with essential hypertensive disease and concomitant type 2 diabetes mellitus. Clinical Medicine, 19(3), s92. https://doi.org/10.7861/clinmedicine.19-3-s92.
Ikwuka, A. O., & Virstyuk, N. G. (2021). Influence of SGLT2 inhibitor and A2RB (AT1) on fibrogenesis and heart failure in patients with essential hypertensive disease combined with diabetes mellitus type 2. E-Poster No. 143 of the 44th & 45th Annual General and Scientific Meeting of the West African College of Physicians (WACP), 1 - 3 November, 2021. https://doi.org/10.13140/RG.2.2.26912.87047.
Ikwuka, A. O., & Virstyuk, N. (2022). Prognostic markers of nephropathy in patients with dual metabolic syndrome diseases (essential hypertensive disease and concomitant type 2 diabetes mellitus). Endocrine Practice, 28(5), S65-S66. https://doi.org/10.1016/j.eprac.2022.03.164.
Ikwuka, A. O. (2023a). Dr. Aloy’s Core Essential Series (DACES) Medical Genetics (1st ed., pp. 9). Science and Education Publishing, USA.
Ikwuka, A. O. (2023b). Dr. Aloy’s Core Essential Series (DACES) Immunology (1st ed., pp. 30) Science and Education Publishing, USA.
Ikwuka, A. O., & Virstyuk, N. (2023c). Patterns and Influence of Cardio-Metabolic Insufficiency in Patients with Essential Hypertensive Disease and Concomitant Type 2 Diabetes Mellitus. Endocrine Practice, 29(5), S32-S33. https://doi.org/10.1016/j.eprac.2023.03.076.
Ikwuka, A. O., Virstyuk, N. G., Luchko, O. R., & Kobitovych, I. (2023)d. Heterogeneity Of Renal Pathogenicity On The Background Of Asymptomatic Hyperuricemia In Patients With Dual Metabolic Syndrome Diseases (Essential Hypertensive Disease and Type 2 Diabetes Mellitus). British Journal of Medical and Health Research, 10(2), 1-9. https://doi.org/10.5281/zenodo.7690636.
Ikwuka, A. O. (2023e). Dr. Aloy’s Core Essential Series (DACES) Hematology (1st ed., pp. 95). Science and Education Publishing, USA.
Ikwuka, A. O., Omoju, D. I., & Mahanera, O. K. (2023)f. Profiling of Clinical Dynamics of Type 2 Diabetes Mellitus in Patients: A Perspective Review. World Journal of Current Medical and Pharmaceutical Research, 5(5), 210-218. Https://doi.org/10.37022/wjcmpr.v5i5.294.
Ikwuka, A. O., Virstyuk, N., Luchko, O., & Kobitovych, I. (2024). Optimization of treatment in MSD patients using a combination of HMG-CoA reductase inhibitor, SGLT-2 inhibitor and A2RB (AT1): Resultant clinical effectiveness. Endocrine Practice, 30(5), S60-S61. https://doi.org/10.1016/j.eprac.2024.03.243.
Inya, A. U., Achara, A. P., Ikwuka, A. O., Udeh, F. C., Chi-kadibia, U., & Onazi, O. (2023a). Patterns, Peculiarities and Associated Risk Factors of Anemia in Pregnancy: A Case Study of Pregnant Women Attending Antenatal Clinic in North-Central Nigeria. European Journal of Preventive Medicine, 11(2), 21-31. Https://doi.org/10.11648/j.ejpm.20231102.12.
Inya, A. U., Achara, A. P., Ikwuka, A. O., Udeh, F. C., Chi-kadibia, U., & Onazi, O. (2023b). Clinical Dynamics of Anemia in Pregnancy: A 16-week Cross-sectional Study of Pregnant Women Who Attended Antenatal Clinic of Federal Medical Center, Keffi, Nasarawa State, Nigeria. American Journal of Clinical Medicine Research, 11(1), 1-9. https://doi.org/10.12691/ajcmr-11-1-1.
Ipinnimo, T., Durowade, K., Afolayan, C., Ajayi, P., & Akande, T. (2022). The Nigeria National Health Insurance Authority Act and its Implications towards Achieving Universal Health Coverage. Nigerian Postgraduate Medical Journal, 29, 281. https://doi.org/10.4103/npmj.npmj_216_22.
Ipinnimo, T. M., Omotoso, A. A., Bamidele, T. A., Sanni, T. A., Ibirongbe, D. O., Ipinnimo, M. T., & Ibikunle, O. O. (2023). Comparing the Nigeria National Health Insurance Scheme Act, 2004 and the National Health Insurance Authority Act, 2022 - What is New and its Implications for the Health System. West Afr J Med, 40(5), 525-532.
Karamagi, H. C., Njuguna, D., Kidane, S. N., Djossou, H., Kipruto, H. K., Seydi, A. B., Nabyonga-Orem, J., Muhongerwa, D. K., Frimpong, K. A., & Nganda, B. M. (2023). Financing health system elements in Africa: A scoping review. PLoS One, 18(9), e0291371. https://doi.org/10.1371/journal.pone.0291371.
Kofoworola, A. A., Ekiye, A., Motunrayo, A. O., Adeoye, A. T., & Adunni, M. R. (2020). National Health Insurance Scheme: An Assessment of Service Quality and Clients’ Dissatisfaction. Ethiop J Health Sci, 30(5), 795-802. https://doi.org/10.4314/ejhs.v30i5.20.
Lee, S., Groß, S. E., Pfaff, H., & Dresen, A. (2020). Waiting time, communication quality, and patient satisfaction: An analysis of moderating influences on the relationship between perceived waiting time and the satisfaction of breast cancer patients during their inpatient stay. Patient Educ Couns, 103(4), 819-825. https://doi.org/10.1016/j.pec.2019.11.018.
Makinde, O. A., Sule, A., Ayankogbe, O., & Boone, D. (2018). Distribution of health facilities in Nigeria: Implications and options for Universal Health Coverage. International Journal of Health Planning and Management, 33(4), e1179-e1192. https://doi.org/10.1002/hpm.2603.
Motaze, N. V., Chi, C. P., Ongolo-Zogo, P., Ndongo, J. S., & Wiysonge, C. S. (2015). Government regulation of private health insurance. Cochrane Database Syst Rev, 4, CD011512. https://doi.org/10.1002/14651858.CD011512.
Nwanaji-Enwerem, O., Bain, P., Marks, Z., Nwanaji-Enwerem, P., Staton, C. A., Olufadeji, A., & Nwanaji-Enwerem, J. C. (2022). Patient satisfaction with the Nigerian National Health Insurance Scheme two decades since establishment: A systematic review and recommendations for improvement. Afr J Prim Health Care Fam Med, 14(1), e1-e10. https://doi.org/10.4102/phcfm.v14i1.3003.
Okah, P., Onalu, C., & Okoye, U. (2023). National Health Insurance Scheme in Nigeria: Exploring Limitations to Utilisation by Adult Enrollees. Journal of Social Service Research, 49(6), 715–730. https://doi.org/10.1080/01488376.2023.2265417.
Okebukola, P. O., & Brieger, W. R. (2016). Providing Universal Health Insurance Coverage in Nigeria. Int Q Community Health Educ, 36(4), 241-246. https://doi.org/10.1177/0272684X16657451.
Onwujekwe, O., Uzochukwu, B., Ibe, O., & Uguru, N. (2012). Health Insurance: principles, models and the Nigerian National Health Insurance Scheme. Journal of College of Medicine, 16(1), 8. https://doi.org/10.4314/jcm.v16i1.8.
Pillah, T. P. (2023). Evaluation of the Performance and Challenges of the National Health Insurance Scheme (NHIS) in Nigeria (2004 – 2021). Journal of Good Governance and Sustainable Development in Africa, 7(3), 36-47.
Roberts, A. A., Balogun, M. R., Sekoni, A. O., Inem, V. A., & Odukoya, O. O. (2015). Healthseeking preferences of residents of Mushin LGA, Lagos: A survey of preferences for provision of maternal and child health services. Journal of Clinical Sciences, 12(1), 9-13. https://doi.org/10.4103/1595-9587.160759.
The Editors of Encyclopaedia Britannica. “Lagos”. (2025). Encyclopaedia Britannica. Available online: https://www.britannica.com/place/Lagos-state-Nigeria
Uche, V. U., Ikwuka, A. O., Udeh, F. C., Okorocha, A. E., Epete, M. A., Ekechi, H. O., Abraham, J. C., & Igwe, E. C. (2023). Associated Risks and Pathogenic Effects of Consumption of Calcium Carbide-Ripened Banana Before and/or During Pregnancy on Maternal and Neonatal Livers. American Journal of Food Science and Technology, 2(2), 54-64. https://doi.org/10.54536/ajfst.v2i2.2197.
Uzochukwu, B. S., Ughasoro, M. D., Etiaba, E., Okwuosa, C., Envuladu, E., & Onwujekwe, O. E. (2015). Health care financing in Nigeria: Implications for achieving universal health coverage. Nigerian Journal of Clinical Practice, 18(4), 437-444. https://doi.org/10.4103/1119-3077.154196.
Virstyuk, N. G., Ikwuka, A. O., Haman, I. O., & Adebomi, M. S. (2016). Diabetes mellitus type 2, arterial hypertension and dyslipidemia. Materials of 2nd International Scientific and Practical Conference “Therapeutic readings: modern aspects of diagnosis and treatment of diseases of internal organs” (pp. 46-47).
Virstyuk, N. G., & Ikwuka, A. O. (2017a). Diagnostic and prognostic markers of the diabetes mellitus type 2 course in connection with essential arterial hypertension taking into account the kidney function. Precarpathian Journal Pulse, 8(44), 53-62.
Virstyuk, N. H., Ikwuka, A. O., Losyuk, L. V., Kobrynska, O. Ya., & Markiv, H. D. (2017b). Dapagliflozin utility in patients with diabetes mellitus type 2 and essential hypertensive disease. Actual Problems of Modern Medicine, 4(60)1, 76-79. Available online: http://www.umsa.edu.ua/journal2stat4_2017_eng.html
Virstyuk, N. G., & Ikwuka, A. O. (2018)a. Features of asymptomatic hyperuricemia in patients with diabetes mellitus type 2 and concomitant essential arterial hypertension. Clinical and Experimental Pathology, 1(63), 22-26. https://doi.org/10.24061/1727-4338.XVII.1.63.2018.5.
Virstyuk, N. G., Ikwuka, A. O., & Didushko, O. M. (2018b). Effect of dapagliflozin on the level of uric acid during asymptomatic hyperuricemia in patients with diabetes mellitus type 2 and concomitant arterial hypertension. Art of Medicine, 1(5), 21-26. Available online: https://art-of-medicine.ifnmu.edu.ua/index.php/aom/article/view/179/150
Virstyuk, N. H., & Ikwuka, A. O. (2018c). Dapagliflozin influence on the clinical course of diabetes mellitus type 2 and essential hypertension in patients. Recent Advances in Environmental Science from the Euro-Mediterranean and Surrounding Regions (pp. 2007-2008). https://doi.org/10.1007/978-3-319-70548-4_582.
Virstyuk, N. G., & Ikwuka, A. O. (2019). Nephropathic characteristics in patients with diabetes mellitus type 2 and essential hypertensive disease. Art of Medicine, 1(5), 44-47. https://doi.org/10.21802/artm.2019.1.9.44.
Virstyuk, N. G., & Ikwuka, A. O. (2021a). Asymptomatic hyperuricemia and functional state of the kidneys in patients with essential arterial hypertension and concomitant diabetes mellitus type 2. European Journal of Clinical Medicine, 2(3), 100-104. https://doi.org/10.24018/clinicmed.2021.2.3.65.
Virstyuk, N. H., Ikwuka, A. O., Luchko, O. R., & Kocherzhat, O. I. (2021b). Peculiarities of renal insufficiency in patients with diabetes mellitus type 2 and arterial hypertension. Materials of scientific-practical conference with international participation “Achievements and prospects of experimental and clinical endocrinology” Twentieth Danilevsky readings (pp. 86-87).
Welcome, M. O. (2011). The Nigerian health care system: Need for integrating adequate medical intelligence and surveillance systems. J Pharm Bioallied Sci, 3(4), 470-478. https://doi.org/10.4103/0975-7406.90.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Ugo Collins Chukwuezie, Aloysius Obinna Ikwuka, Ifeoma Theresa Mmegwa, Solomon Musa, Chinenye Helen Emeribe, Samson Babalola
This work is licensed under a Creative Commons Attribution 4.0 International License.
